Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
PULMOCIDE LIMITED
2661
PULMOCIDE LIMITED
Health Care
Technology
Biotechnology
Medical
Diagnostics
Health Diagnostics
Pulmocide is focused on the development of inhaled medicines for the treatmentof viral and fungal infections of the respiratory tract.
Suggest edits
Type
B2c
Founded
2013
Raised
$58M
Follow us
Also headquartered in London
Blockchain
Reuters
BBC
Cambridge Analytica
HSBC
DeepMind
Ubuntu
Volkswagen
WPP
Revolut
Companies in the same industry
Congenica
GoodGut
Fusion Genomics
Enterome Bioscience
Epinex Diagnostics
NanoCellect Biomedical
myTomorrows
Habcan lifescience Co.Ltd
EndoChoice
Prometic
Alexa global traffic share
Overview
Funding
2
Add info
Latest funding
$30,000,000
Venture capital (Series B) - 2017
SV Life Sciences
F-Prime Capital Partners
Johnson & Johnson
+2
$27,541,217
Venture capital (Series A) - 2013
Team Size
10+
Employees
I work here
Location
London
,
United Kingdom
Headquarters
Explore London
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when PULMOCIDE LIMITED makes some noise.
